MYONEXUS THERAPEUTICS
Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy (LGMD) Types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children’s Hospital, a global leader in muscular dystrophy gene therapy discovery and translational research.
MYONEXUS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-02-01
Address:
Columbus, Ohio, United States
Country:
United States
Website Url:
http://www.myonexustx.com
Total Employee:
1+
Status:
Active
Contact:
614.477.5445
Email Addresses:
[email protected]
Total Funding:
62.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Google Maps API Google Maps For Work CSC Global DNS
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Founder
Investors List
Sarepta Therapeutics
Sarepta Therapeutics investment in Corporate Round - Myonexus Therapeutics
Rev1 Ventures
Rev1 Ventures investment in Seed Round - Myonexus Therapeutics
GFB ONLUS
GFB ONLUS investment in Seed Round - Myonexus Therapeutics
CincyTech
CincyTech investment in Seed Round - Myonexus Therapeutics
Jain Foundation
Jain Foundation investment in Seed Round - Myonexus Therapeutics
Official Site Inspections
http://www.myonexustx.com
- Host name: 165.160.13.20
- IP address: 165.160.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Myonexus Therapeutics"
Myonexus Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 614.477.5445 Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for Limb …See details»
Myonexus Company Profile - Craft
Feb 27, 2019 Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing treatments for Limb-girdle muscular dystrophy Types 2D, 2B, 2E, 2L, and 2C.See details»
Myonexus Therapeutics - PitchBook
Myonexus Therapeutics General Information Description. Developer of a rare disease gene therapy designed to treat Limb-girdle muscular dystrophies …See details»
Myonexus Therapeutics - VentureRadar
Gene Therapy Research Institute (GTRI) Japan n/a Gene Therapy Research Institution Co., Ltd. (GTRI) is a pioneering organization in the field of gene therapy, focusing primarily on …See details»
Myonexus Therapeutics - 2025 Company Profile - Tracxn
Myonexus Therapeutics - Clinical stage gene therapy company developing treatments for Limb-girdle muscular dystrophy (LGMD). Acquired by Sarepta. Raised a total funding of $2.5M over …See details»
Myonexus Therapeutics - Funding, Financials, Valuation & Investors
Myonexus Therapeutics is a clinical stage gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy types.See details»
Myonexus Therapeutics, Inc. Overview | SignalHire Company Profile
Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first-ever, corrective treatments for Limb-girdle muscular dystrophy (LGMD) Types 2E, 2D, 2B, 2C, …See details»
Myonexus Therapeutics - Innovate New Albany
Feb 6, 2018 Myonexus Therapeutics. Myonexus Therapeutics is a clinical stage gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy (LGMD) types …See details»
Myonexus Therapeutics - Rev1 Ventures
Company Profile. Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb-girdle muscular dystrophy (LGMD) types 2D, 2B, 2E, 2L, and 2C based on research at …See details»
Myonexus Therapeutics Inc - Company Info, Employees
View Myonexus therapeutics inc myonexustx.com location in Usa, revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»
Myonexus Therapeutics Inc Email and Phone | Salezshark
Explore all about Myonexus Therapeutics Inc and view email ID and phone Number of CEO, Founder, CMO, CXO, Directors and other key employees in the companySee details»
Truth About Myonexus therapeutics, inc.. Is Myonexus …
Myonexus therapeutics, inc. Review Reviews 12. 4.2See details»
Myonexus Therapeutics Secures $2.5 Million Seed ... - Rev1 Ventures
Dec 13, 2017 [email protected]. Peg Rusconi CincyTech 617-910-6217 [email protected]. Aimee Eichelberger Rev1 Ventures [email protected] …See details»
Sarepta to buy Myonexus for $165 mln in gene therapy push
Feb 27, 2019 Sarepta Therapeutics Inc said on Wednesday it would buy privately held gene therapy company Myonexus Therapeutics Inc for $165 million, moving deeper into an …See details»
Myonexus: A clinical stage gene therapy company developing …
Dec 13, 2017 Myonexus Poised to Unlock Gene Therapy for Limb-Girdle Muscular Dystrophy. Myonexus Therapeutics is a clinical stage gene therapy company developing first-ever gene …See details»
Myonexus Therapeutics Receives Orphan Drug Designation for …
Jan 2, 2019 Media and Investors: Myonexus Therapeutics Laureen Cassidy, [email protected] Media Contact for Nationwide Children’s Hospital: Gina Bericchia …See details»
Myonexus Therapeutics Announces Accelerated Acquisition by …
Feb 27, 2019 More information is available at myonexustx.com. William Blair served as financial advisers and Thompson Hine LLP and Fenwick & West LLP served as legal advisers to …See details»
Myonexus Therapeutics-动脉网
[email protected] Myonexus Therapeutics是一家生物技术公司，专注于临床阶段罕见疾病的基因疗法。 Myonexus Therapeutics在全国儿童医院关于肌萎缩症基因治疗领先的技术基础 …See details»
Myonexus Therapeutics_医疗项目_动脉网数据 - vbdata.cn
动脉网数据库，Myonexus Therapeutics是一家生物技术公司，专注于临床阶段罕见疾病的基因疗法。Myonexus Therapeutics在全国儿童医院关于肌萎缩症基因治疗领先的技术基础上，首次 …See details»
BlockID
Error Code: A00006. JourneyId: f48083e3-77ba-4c85-937c-3f0aa40288b2See details»